Latest Europe News

Pro Medicus Limited delivered a robust half-year performance ending December 2024, with after-tax profits soaring 42.7% to $51.74 million and revenues climbing 31.1% to $97.2 million, driven by significant contract wins in North America and sustained growth in Australia.

Latitude 66 Limited is set to commence a pioneering Reverse Circulation (RC) drilling trial at its KSB North Project in Finland, aiming to unlock high-grade gold and cobalt mineralisation at the K6E and K6W Prospects. This move could significantly enhance exploration efficiency and reduce costs across the project.

Orora reports a 24.6% rise in underlying EBIT to $120.8 million for H1 FY25, driven by the Saverglass acquisition and portfolio simplification, while navigating operational challenges and market headwinds.

Magnum Mining & Exploration is recalibrating its supply chain strategy in response to new U.S. tariffs on steel and aluminium, engaging with Chinese partners and advancing its Buena Vista iron project.

Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.

Amotiv Limited reported a modest 2.3% revenue increase in the first half of FY25, underpinned by acquisitions and strategic initiatives despite organic revenue softness and margin pressures. The company anticipates a stronger second half driven by new business wins and pricing actions.

Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.

CSL Limited posted a robust half-year performance with NPATA rising 5% at constant currency, driven by strong growth in CSL Behring and CSL Vifor despite challenges in its influenza vaccine segment. The company reaffirmed its FY25 guidance, anticipating double-digit earnings growth.

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.

Black Dragon Gold has applied for its Salave Gold Project to be designated a Strategic Investment Project under new regional legislation in Asturias, aiming to fast-track development and boost local economic benefits.

Critical Metals Corp. has secured US$22.5 million through a private placement to advance its Tanbreez Rare Earth Project in Greenland and Wolfsberg Lithium Project in Austria, reinforcing its position in the critical metals supply chain for Europe.